The value of the 'classical' binary approaches to define genotypic sensitivity and phenotypic sensitivity scores for optimization of background HIV therapy in patients with extensive HIV drug ...

Legacy’s trusted health care professionals are here to help patients living with HIV start and stay on treatment. Legacy ...

Background on Transplantation in People Living With HIV Modern medication regimens have transformed HIV from a deadly disease into a chronic disease, with some patients now surviving more than 40 ...

Cooper DA et al. Subgroup and resistance analysis of raltegravir for resistant HIV-1 infection. New England Journal of Medicine, 359: 355-365, 2008. Steigbigel RT et al. Raltegravir with optimized ...

References Lalezari J et al. Efficacy and safety of maraviroc plus optimized background therapy in viremic ART-experienced patients infected with CCR5-tropic HIV-1: 24 week results from a phase 2b/3 ...